AT362492B - Verfahren zur herstellung eines stabilen insulinpraeparats mit dauerwirkung - Google Patents

Verfahren zur herstellung eines stabilen insulinpraeparats mit dauerwirkung

Info

Publication number
AT362492B
AT362492B AT21376A AT21376A AT362492B AT 362492 B AT362492 B AT 362492B AT 21376 A AT21376 A AT 21376A AT 21376 A AT21376 A AT 21376A AT 362492 B AT362492 B AT 362492B
Authority
AT
Austria
Prior art keywords
producing
insulin preparation
permanent effect
stable insulin
stable
Prior art date
Application number
AT21376A
Other languages
German (de)
English (en)
Other versions
ATA21376A (de
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of ATA21376A publication Critical patent/ATA21376A/de
Application granted granted Critical
Publication of AT362492B publication Critical patent/AT362492B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT21376A 1975-01-15 1976-01-14 Verfahren zur herstellung eines stabilen insulinpraeparats mit dauerwirkung AT362492B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (da) 1975-01-15 1975-01-15 Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.

Publications (2)

Publication Number Publication Date
ATA21376A ATA21376A (de) 1980-10-15
AT362492B true AT362492B (de) 1981-05-25

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
AT21376A AT362492B (de) 1975-01-15 1976-01-14 Verfahren zur herstellung eines stabilen insulinpraeparats mit dauerwirkung

Country Status (36)

Country Link
JP (1) JPS5946939B2 (sv)
AR (1) AR213088A1 (sv)
AT (1) AT362492B (sv)
BE (1) BE837600A (sv)
BR (1) BR7600206A (sv)
CA (1) CA1094549A (sv)
CH (1) CH631625A5 (sv)
CS (1) CS208147B2 (sv)
DD (1) DD124379A5 (sv)
DE (1) DE2600971C2 (sv)
DK (1) DK140801B (sv)
EG (1) EG11988A (sv)
ES (1) ES444558A1 (sv)
FI (1) FI66751C (sv)
FR (1) FR2297634A1 (sv)
GB (1) GB1524431A (sv)
GR (1) GR58608B (sv)
HU (1) HU175142B (sv)
IE (1) IE42395B1 (sv)
IL (1) IL48845A (sv)
IN (1) IN143279B (sv)
IT (1) IT1054211B (sv)
KE (1) KE2919A (sv)
LU (1) LU74175A1 (sv)
MX (1) MX4052E (sv)
MY (1) MY7900169A (sv)
NL (1) NL166464C (sv)
NO (1) NO146698C (sv)
NZ (1) NZ179733A (sv)
OA (1) OA05209A (sv)
PL (1) PL99927B1 (sv)
PT (1) PT64696B (sv)
RO (1) RO71576A (sv)
SE (1) SE437219B (sv)
YU (1) YU8376A (sv)
ZA (1) ZA7658B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (da) * 1979-09-07 1981-03-08 Nordisk Insulinlab Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010112358A2 (de) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
NZ724449A (en) 2014-05-07 2022-01-28 Boehringer Ingelheim Int Nebulizer and container
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
FI760058A (sv) 1976-07-16
IN143279B (sv) 1977-10-29
AU1030776A (en) 1977-07-21
MY7900169A (en) 1979-12-31
PT64696A (fr) 1976-02-01
PL99927B1 (pl) 1978-08-31
BE837600A (fr) 1976-07-15
ATA21376A (de) 1980-10-15
JPS5946939B2 (ja) 1984-11-15
IE42395B1 (en) 1980-07-30
IT1054211B (it) 1981-11-10
CH631625A5 (en) 1982-08-31
DE2600971A1 (de) 1976-07-22
EG11988A (en) 1978-06-30
DE2600971C2 (de) 1985-12-12
NO760118L (sv) 1976-07-16
LU74175A1 (sv) 1977-03-18
DD124379A5 (sv) 1977-02-16
NL7600338A (nl) 1976-07-19
PT64696B (fr) 1977-08-10
OA05209A (fr) 1981-02-28
JPS51125299A (en) 1976-11-01
AR213088A1 (es) 1978-12-15
CS208147B2 (en) 1981-08-31
BR7600206A (pt) 1976-08-31
NL166464B (nl) 1981-03-16
NO146698C (no) 1982-11-24
NZ179733A (en) 1978-04-28
DK8375A (sv) 1976-07-16
ES444558A1 (es) 1977-05-16
GB1524431A (en) 1978-09-13
NL166464C (nl) 1981-08-17
IE42395L (en) 1976-07-15
HU175142B (hu) 1980-05-28
FR2297634A1 (fr) 1976-08-13
NO146698B (no) 1982-08-16
YU8376A (en) 1982-06-30
MX4052E (es) 1981-11-24
IL48845A0 (en) 1976-03-31
SE437219B (sv) 1985-02-18
FR2297634B1 (sv) 1979-03-30
FI66751B (fi) 1984-08-31
DK140801B (da) 1979-11-19
DK140801C (sv) 1980-04-21
SE7600284L (sv) 1976-07-16
GR58608B (en) 1977-11-10
KE2919A (en) 1979-03-30
RO71576A (ro) 1980-12-30
IL48845A (en) 1981-06-29
ZA7658B (en) 1976-12-29
FI66751C (fi) 1984-12-10
CA1094549A (en) 1981-01-27

Similar Documents

Publication Publication Date Title
AT362492B (de) Verfahren zur herstellung eines stabilen insulinpraeparats mit dauerwirkung
ATA971776A (de) Verfahren zur herstellung eines stabilen antibiotischen praparates
AT354636B (de) Verfahren zur herstellung eines praeparates mit gesteuerter abgabe einer aktiven komponente
DD133519A5 (de) Verfahren zur herstellung eines stuetzverbands
AT346228B (de) Verfahren zur herstellung eines kunststoff- -fasses
AT347038B (de) Verfahren zur herstellung eines diaetpraeparats
DD132786A5 (de) Verfahren zur herstellung eines neuen oximaethers
AT353415B (de) Verfahren zur herstellung eines pharma- zeutischen praeparates
AT361280B (de) Verfahren zur herstellung eines stabilen nahrungs- und futtermittels
AT349870B (de) Verfahren zur herstellung eines kaffee- extraktes
AT361332B (de) Verfahren zur herstellung eines einlegesohlen- materials
AT344327B (de) Verfahren zur herstellung eines rektal anwendbaren pharmazeutischen praeparates
DD131019A5 (de) Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides
AT337978B (de) Verfahren zur herstellung eines stabilisierten oxymethylencopolymeren
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT348489B (de) Verfahren zur herstellung eines plaettchen- foermigen calcium-magnesium-carbonat-gemisches mit basischem charakter
AT366056B (de) Verfahren zur herstellung eines phosphordichloridothiolats
ATA580375A (de) Verfahren zur herstellung eines reinen ceroxids
AT360099B (de) Verfahren zur herstellung eines mikroporoesen batteriescheiders
AT362055B (de) Verfahren zur herstellung eines stabilen baldrianextraktpraeparates
AT358723B (de) Verfahren zur herstellung eines lipasereichen enzympraeparates
AT355725B (de) Verfahren zur herstellung stabiler loesungen
AT357855B (de) Verfahren zur herstellung eines pektin- praeparates
AT349293B (de) Verfahren zur herstellung eines tee-extraktes
DD133672A5 (de) Verfahren zur herstellung eines saeureadditionssalzes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee